Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica
- 11 December 2008
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 39 (1) , 87-90
Abstract
We systematically evaluated the frequency of neurological disorders and muscle and neural autoantibodies in 177 patients with neuromyelitis optica (NMO) and in 250 control subjects (173 healthy; 77 multiple sclerosis, MS, patients). An excess of myasthenia gravis (MG, 2%), and muscle‐type acetylcholine receptor antibody (11%) was detected among NMO patients. The presence of neural or muscle autoantibodies was more common in NMO patients (34%) than in MS patients or healthy controls (7%), P < 0.0001. The coexistence of NMO and MG should be considered in atypical or refractory presentations of either disorder. © 2008 Wiley Periodicals, Inc. Muscle Nerve 39: 87–90, 2009Keywords
This publication has 22 references indexed in Scilit:
- NMO-IgG predicts the outcome of recurrent optic neuritisNeurology, 2008
- Autoimmune myelopathy associated with collapsin response‐mediator protein‐5 immunoglobulin GAnnals of Neurology, 2008
- Clinical and laboratory‐reconfirmed myasthenia gravis: a population‐based studyEuropean Journal of Neurology, 2008
- Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis opticaNeurology, 2007
- Neuromyelitis optica associated with myasthenia gravis: characteristic phenotype in Japanese populationEuropean Journal of Neurology, 2006
- Neuromyelitis Optica in Patients With Myasthenia Gravis Who Underwent ThymectomyArchives of Neurology, 2006
- IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channelJournal of Experimental Medicine, 2005
- Anti-glial nuclear antibody: Marker of lung cancer-related paraneoplastic neurological syndromesJournal of Neuroimmunology, 2005
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 2001